These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1574 related items for PubMed ID: 12683337

  • 1. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M, Akagawa K, Kobayashi K, Sugawara I, Kawakami K, Yamamoto S, Okada Z.
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 4. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 6. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J, Ma H, Qu Q, Zhou WJ, Luo YP, Thangaraj H, Lowrie DB, Fan XY.
    Vaccine; 2011 Oct 13; 29(44):7624-30. PubMed ID: 21856352
    [Abstract] [Full Text] [Related]

  • 7. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J, Xu W, Chen X, Zhao D, Wang Y.
    Vaccine; 2008 Aug 18; 26(35):4519-25. PubMed ID: 18598729
    [Abstract] [Full Text] [Related]

  • 8. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.
    Pediatrics; 2006 May 18; 117(5):e878-86. PubMed ID: 16618789
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 18; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 10. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
    Li H, Li R, Zhong S, Ren H.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr 18; 23(4):291-4. PubMed ID: 17428378
    [Abstract] [Full Text] [Related]

  • 11. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM, Ryan AA, Triccas JA, Britton WJ.
    Infect Immun; 2006 Jan 18; 74(1):557-65. PubMed ID: 16369012
    [Abstract] [Full Text] [Related]

  • 12. [Recent progress in mycobacteriology].
    Okada M, Kobayashi K.
    Kekkaku; 2007 Oct 18; 82(10):783-99. PubMed ID: 18018602
    [Abstract] [Full Text] [Related]

  • 13. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M.
    Vaccine; 2006 Feb 20; 24(8):1191-204. PubMed ID: 16216394
    [Abstract] [Full Text] [Related]

  • 14. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep 20; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 15. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H, Li K, Yu S, Xiong S.
    Microbiol Immunol; 2009 Oct 20; 53(10):541-9. PubMed ID: 19780967
    [Abstract] [Full Text] [Related]

  • 16. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S, Gong Q, Wang C, Liu H, Wang Y, Guo S, Wang W, Liu J, Shao M, Chi L, Zhao K, Wang Z, Shi Y, Huang Y, Guli A, Zhang C, Kong X.
    Immunol Lett; 2008 May 15; 117(2):136-45. PubMed ID: 18339431
    [Abstract] [Full Text] [Related]

  • 17. [Factors for the onset of and the exacerbation of tuberculosis. 2. Host factors promoting the occurrence and exacerbation of tuberculosis: significance of Th1-Th2 cytokine balance].
    Kawakami K.
    Kekkaku; 1999 Oct 15; 74(10):735-40. PubMed ID: 10565134
    [Abstract] [Full Text] [Related]

  • 18. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
    Sin JI, Kim JJ, Arnold RL, Shroff KE, McCallus D, Pachuk C, McElhiney SP, Wolf MW, Pompa-de Bruin SJ, Higgins TJ, Ciccarelli RB, Weiner DB.
    J Immunol; 1999 Mar 01; 162(5):2912-21. PubMed ID: 10072541
    [Abstract] [Full Text] [Related]

  • 19. [Mechanisms of pathogenicity and host defense in infections by intracellular parasitic microbes].
    Mitsuyama M, Suzuki K.
    Kekkaku; 2000 Sep 01; 75(9):557-60. PubMed ID: 11068372
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB, Davis BK, Zhou XD, Chen SJ, Finkelman FD, Gause WC.
    Virology; 1997 Jul 07; 233(2):302-12. PubMed ID: 9217054
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 79.